Track the REPROS THERAPEUTICS INC. share price and the full insider trade history of the company, a publicly traded company based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €33.6bn. The latest transaction was disclosed on 28 January 2016 (Acquisition). Among the most active insiders: Wernicke J. F.. Every trade is openly available.
6
Insider Decl.
n/a
Thresholds
n/a
6 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate REPROS THERAPEUTICS INC. Buy (bullish), based on 9 analysts. Average price target: US$59.89.
Fundamental score
Ranked 13,667 of 28,932 companies
53.5
score / 100
Value
46
Quality
62
FCF yld7.4%
Earn yld2.3%
EV/EBITDA26.0x
ROE14%
Gross mgn·
Net mgn32%
Debt/EBITDA5.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
REPROS THERAPEUTICS INC. is a biopharmaceutical company focused on developing treatments for hormonal and reproductive disorders. It is listed on NASDAQ under the ticker RPRX.